Treating Acne in Obese and Morbidly Obese Patients With Tazarotene 0.045% Lotion: Post Hoc Analysis of Pooled Phase 3 Data. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s12, 2022. DOI: 10.25251/skin.6.supp.12. Disponível em: https://skin.dermsquared.com/skin/article/view/1529. Acesso em: 18 apr. 2025.